2005 "Swine" Flu

Emerging Infectious Diseses, Volume 14, Number 9–September 2008
Dispatch
Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin
Alexandra P. Newman,1 Erik Reisdorf, Jeanne Beinemann, Timothy M. Uyeki, Amanda Balish, Bo Shu, Stephen Lindstrom, Jenna Achenbach, Catherine Smith, and Jeffrey P. Davis
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.P. Newman, T.M. Uyeki, A. Balish, B. Shu, S. Lindstrom, J. Achenbach, C. Smith); Wisconsin Division of Public Health, Madison, Wisconsin, USA (A.P. Newman, J.P. Davis); Wisconsin State Laboratory of Hygiene, Madison (E. Reisdorf); and Sheboygan County Health and Human Services, Sheboygan, Wisconsin, USA (J. Beinemann)

Abstract
Zoonotic infections with swine influenza A viruses are reported sporadically. Triple reassortant swine influenza viruses have been isolated from pigs in the United States since 1998. We report a human case of upper respiratory illness associated with swine influenza A (H1N1) triple reassortant virus infection that occurred during 2005 following exposure to freshly killed pigs.

http://www.cdc.gov/eid/content/14/9/1470.htm
Suggested citation for this article
Newman AP, Reisdorf E, Beinemann J, Uyeki TM, Balish A, Shu B, et al. Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis [serial on the Internet]. 2008 Sep [date cited]. Available from http://www.cdc.gov/EID/content/14/9/1470.htm

DOI: 10.3201/eid1409.080305
1Current affiliation: New York State Department of Health, Albany, New York, USA.

Find more articles by entering 'Tamiflu' or 'Flu' in the search window.

Wednesday, November 29, 2006
Tamiflu dangers reported
OTTAWA (Reuters) - Canada has asked Swiss drug maker Roche AG to warn consumers of possible health risks linked to its influenza drug Tamiflu, the health department said on Wednesday.

Ottawa took the step after receiving international reports of side-effects such as hallucinations and abnormal behavior, including self-harm. The reports include cases involving children and teenagers, primarily in Japan.

"Health Canada has requested that the manufacturer ... update the Canadian prescribing information for Tamiflu to include this new information," the department said in a statement.

According to Health Canada, there have been 84 reports as of November 11 of Canadian patients having adverse effects when using Tamiflu. Ten of those cases involved fatalities...

Tamiflu not effective
Relenza, Tamiflu
Tamiflu